Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study

PURPOSE: To assess the efficacy and safety of docetaxel rechallenge in the salvage setting in metastatic castration-resistant prostate cancer (mCRPC) patients. MATERIALS AND METHODS: Clinicopathologic data from patients treated with docetaxel rechallenge were collected from a single-center cancer re...

Descripción completa

Detalles Bibliográficos
Autores principales: Byeon, Seonggyu, Kim, Hyera, Kim, Jinchul, Kwon, Minsuk, Hur, Joon Young, Jeon, Hwang Gyun, Jeon, Seong Soo, Lee, Hyun Moo, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606124/
https://www.ncbi.nlm.nih.gov/pubmed/32985144
http://dx.doi.org/10.4111/icu.20200214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606124/
https://www.ncbi.nlm.nih.gov/pubmed/32985144
http://dx.doi.org/10.4111/icu.20200214

Ejemplares similares